Literature DB >> 24775301

Design and synthesis of molecular probes for the determination of the target of the anthelmintic drug praziquantel.

Lalit Kumar Sharma1, Pauline M Cupit2, Tino Goronga1, Thomas R Webb1, Charles Cunningham3.   

Abstract

Schistosomiasis is a highly prevalent neglected tropical disease caused by blood-dwelling helminths of the genus Schistosoma. Praziquantel (PZQ) is the only drug available widely for the treatment of this disease and is administered in racemic form, even though only the (R)-isomer has significant anthelmintic activity. Progress towards the development of a second generation of anthelmintics is hampered by a lack of understanding of the mechanism of action of PZQ. In this Letter, we report an efficient protocol for the small-scale separation of enantiomers of 2 (hydrolyzed PZQ) using supercritical fluid chromatography (SFC). The enantiopure 2 was then used to develop several molecular probes, which can potentially be used to help identify the protein target of PZQ and study its mode of action.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anthelmintic; Molecular probes; Praziquantel; Schistosomiasis; Supercritical fluid chromatography (SFC)

Mesh:

Substances:

Year:  2014        PMID: 24775301      PMCID: PMC4055354          DOI: 10.1016/j.bmcl.2014.04.014

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  29 in total

1.  Sex- and stage-related sensitivity of Schistosoma mansoni to in vivo and in vitro praziquantel treatment.

Authors:  Livia Pica-Mattoccia; Donato Cioli
Journal:  Int J Parasitol       Date:  2004-03-29       Impact factor: 3.981

Review 2.  Application of supercritical fluid carbon dioxide to the extraction and analysis of lipids.

Authors:  Jae Won Lee; Eiichiro Fukusaki; Takeshi Bamba
Journal:  Bioanalysis       Date:  2012-10       Impact factor: 2.681

3.  Comparative in vitro and in vivo activity of racemic praziquantel and its levorotated isomer on Schistosoma mansoni.

Authors:  S H Xiao; B A Catto
Journal:  J Infect Dis       Date:  1989-03       Impact factor: 5.226

Review 4.  Antischistosomal drugs: past, present ... and future?

Authors:  D Cioli; L Pica-Mattoccia; S Archer
Journal:  Pharmacol Ther       Date:  1995       Impact factor: 12.310

5.  Opposing roles of voltage-gated Ca2+ channels in neuronal control of regenerative patterning.

Authors:  Dan Zhang; John D Chan; Taisaku Nogi; Jonathan S Marchant
Journal:  J Neurosci       Date:  2011-11-02       Impact factor: 6.167

6.  Comparison of the therapeutic efficacy and side effects of a single dose of levo-praziquantel with mixed isomer praziquantel in 278 cases of schistosomiasis japonica.

Authors:  M H Wu; C C Wei; Z Y Xu; H C Yuan; W N Lian; Q J Yang; M Chen; Q W Jiang; C Z Wang; S J Zhang
Journal:  Am J Trop Med Hyg       Date:  1991-09       Impact factor: 2.345

7.  Towards an understanding of the mechanism of action of praziquantel.

Authors:  Anthony D Aragon; Reza A Imani; Vint R Blackburn; Pauline M Cupit; Sandra D Melman; Tinopiwa Goronga; Thomas Webb; Eric S Loker; Charles Cunningham
Journal:  Mol Biochem Parasitol       Date:  2008-11-28       Impact factor: 1.759

Review 8.  Praziquantel.

Authors:  Donato Cioli; Livia Pica-Mattoccia
Journal:  Parasitol Res       Date:  2002-11-22       Impact factor: 2.289

9.  Praziquantel, a new board-spectrum antischistosomal agent.

Authors:  R Gönnert; P Andrews
Journal:  Z Parasitenkd       Date:  1977-07-21

10.  Reduced susceptibility to praziquantel among naturally occurring Kenyan isolates of Schistosoma mansoni.

Authors:  Sandra D Melman; Michelle L Steinauer; Charles Cunningham; Laura S Kubatko; Ibrahim N Mwangi; Nirvana Barker Wynn; Martin W Mutuku; Diana M S Karanja; Daniel G Colley; Carla L Black; William Evan Secor; Gerald M Mkoji; Eric S Loker
Journal:  PLoS Negl Trop Dis       Date:  2009-08-18
View more
  1 in total

1.  Inhibition or knockdown of ABC transporters enhances susceptibility of adult and juvenile schistosomes to Praziquantel.

Authors:  Ravi S Kasinathan; Lalit Kumar Sharma; Charles Cunningham; Thomas R Webb; Robert M Greenberg
Journal:  PLoS Negl Trop Dis       Date:  2014-10-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.